Saturday, October 3, 2026

BTC $84,669 ▼ 2.04%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$84,669−2.04%ETH$2,685−2.25%SOL$119.38−2.07%XRP$1.49−3.02%LINK$13.93−3.29%ADA$0.245−3.87%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,162.30−0.95%SILVER$60.42−1.24%OIL$91.11−1.90%DXY101.92−0.01%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed67 — GreedBTC$84,669−2.04%ETH$2,685−2.25%SOL$119.38−2.07%XRP$1.49−3.02%LINK$13.93−3.29%ADA$0.245−3.87%S&P 5007,723+0.73%Nasdaq27,191+1.19%Dow51,177+0.49%RUT2,833+0.94%TNX5.28%+0.76%TYX5.63%+0.48%FVX5.05%+1.00%IRX3.99%+0.28%VIX15.31−6.59%GOLD$4,162.30−0.95%SILVER$60.42−1.24%OIL$91.11−1.90%DXY101.92−0.01%NVDA$233.95+1.34%AAPL$333.69+1.02%TSLA$370.59+4.65%META$728.08+0.30%MSFT$517.53+0.92%AMZN$251.52+1.33%GOOGL$343.50+1.56%Fear & Greed67 — Greed

Tag

abbv

1 article

U.S. Equities1h ago

AbbVie's Juvmo Approval Validates $8.7B Cerevel Bet, Eyes $1.4B Peak Sales

FDA approval of Juvmo, AbbVie's once-daily Parkinson's treatment, delivers near-term validation of its Cerevel acquisition and positions a new growth driver as Humira patent cliff deepens.